Longevity Health Holdings Inc.
Longevity Health Holdings Inc.
Your view on XAGE
Overview
What the company does, where it operates, and who runs it.
About Longevity Health Holdings Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Rajiv Sarman Shukla
- Headquarters
- 2403 Sidney Street, Pittsburgh, PA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Rajiv Sarman Shukla
- Headquarters
- 2403 Sidney Street, Pittsburgh, PA, US
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging.
Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Longevity Health Holdings Inc., and the rating behind it. XAGE last traded at $0.28; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Longevity Health Holdings Inc.. Starting points for Longevity Health Holdings Inc.: EPS -$2.76, beta 0.37 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Longevity Health Holdings Inc.. Longevity Health Holdings Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Longevity Health Holdings Inc.. Trailing twelve-month EPS for Longevity Health Holdings Inc. stands at -$2.76. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Longevity Health Holdings Inc.. Longevity Health Holdings Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Longevity Health Holdings Inc. valued side by side against its closest peers. Longevity Health Holdings Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Longevity Health Holdings Inc., and how their positions are changing. At a $415,447 market value, institutional positions materially move Longevity Health Holdings Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Longevity Health Holdings Inc. executives and directors. Shares of Longevity Health Holdings Inc. have traded between $0.28 and $13.26 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Longevity Health Holdings Inc.. Longevity Health Holdings Inc. is a $415,447 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Longevity Health Holdings Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Longevity Health Holdings Inc.. Coverage tracks Longevity Health Holdings Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.